Announcement on Convening the 2024 Annual Performance Briefing
Filed with SSE · · 3 pages · Chinese
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Earlier from Tianjin Tianyao Pharmaceuticals
- Announcement on Receiving Decision for Administrative Penalty
- Announcement on Provision for Impairment
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection
Later from Tianjin Tianyao Pharmaceuticals
- Announcement on Reply to Letter of Inquiry on Post Audit of 2024 Annual Report
- Announcement on Outline of the 2024 Annual Performance Briefing
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Resolution of the 17th Meeting of the 9th Board of Directors
- Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals